60 stories tagged with #pharm, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Pharm"
Is the VanEck Pharmaceutical ETF or State Street Health Care ETF the Better Buy for Your Portfolio?
Govt firm on 50% merit quota for Pharm D admissions: Minister
Kerala government insists on 50% merit quota for Pharm D admissions, despite challenges from the Self Financing Pharmacy College Association.…
Cloudbreak Pharma Inc (CDBKF) - Morningstar
Top Hydroxychloroquine Sulfate Active Pharmaceutical Ingredient Suppliers in The City (CAS No. 747-36-4)
Top Hydroxychloroquine Sulfate Active Pharmaceutical Ingredient Suppliers in The City (CAS No. 747-36-4)…
NewAmsterdam Pharma: Obicetrapib Is More Than Another LDL-Lowering Pill
NewAmsterdam Pharma (NAMS) outlook: obicetrapib could cut cardiovascular risk beyond LDL-C. Key catalysts into 2026–27; valuation execution risk.…
A Leading Omeprazole Sodium Sterile Pharmaceutical Ingredient Producer (CAS 95510-70-6)
A Leading Omeprazole Sodium Sterile Pharmaceutical Ingredient Producer (CAS 95510-70-6)…
Medications Already in Pharmacies May Slow Aging, And Scientists Are Narrowing Them Down
In the quest to find ways to help us live at a healthier level for a longer period of time, researchers are turning to existing drugs for clues.…
NewAmsterdam Pharma et le groupe Menarini reçoivent un avis favorable du CHMP recommandant l'autorisation de mise sur le marché d'Ubeslo® (obicetrapib en monothérapie) et d'Evlarco® (association à dose fixe d'obicetrapib et d'ézétimibe)
/PRNewswire/ -- NewAmsterdam Pharma Company N.V. (Nasdaq : NAMS (ou « NewAmsterdam » ou la « Société »), une société biopharmaceutique spécialisée dans les...…
Gift Establishes School of Pharmacy’s First Presidential Chair
The best coupons at CVS Pharmacy
Make Telangana safest manufacturing location, official tells pharma industry
Telangana officials emphasize prioritizing safety in pharma manufacturing to enhance competitiveness and establish the region as a global leader.…
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Earnings call transcript: OneSource Specialty Pharma posts strong Q1 2027 growth
Pharmaceutical Formulations: A Deep Dive into APIs , Nutraceuticals , and Inactive Ingredients
Pharmaceutical Formulations: A Deep Dive into APIs , Nutraceuticals , and Inactive Ingredients…
GLP-1s are changing US healthcare, should everyone be on them?
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.…
Regeneron: I'm Not Concerned About The Declining ROIC And Operating Margins
Regeneron Pharmaceuticals, Inc. buy case: Dupixent & Libtayo fuel growth despite volatility & Eylea biosimilar risks; margins to recover. Click for an REGN update.…
Pharma task force urges Health Canada to streamline regulatory reviews as part of suite of recommendations
Group was formed to advise Ottawa on how to support the industry and ensure access to medication in the midst of developments such as USMCA talks…
Form S-3ASR BridgeBio Pharma Inc For: 24 July
China SXT Pharmaceuticals raises $9M in direct offering
Form 144 Olema Pharmaceuticals For: 24 July
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call July 24, 2026 4:00 AM EDTCompany ParticipantsKae Miyata - Head of Corporate Communications...…
Form S-1/A CTT Pharmaceutical Holdings Inc For: 24 July
Tarsus Pharmaceuticals: Q2 2026 Rebound In Sales Possible, Catalysts Approaching
Tarsus experienced a dip in net product sales in Q1'26, relative to Q4'25, the first decrease since Xdemvy launched. Learn more about TARS stock here.…
Legend Biotech: Why I'm Ready To Go Long Again
Legend Biotech Corporation stock: strong Carvykti demand lifts Q2 sales; LB2501 CAR-T shows Phase 1 promise. Click for this LEGN update.…
West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift
West Pharmaceutical Services beats Q2 earnings, raises FY guidance, and sees biologics-driven margin gains. Click to read this earnings analysis of WST stock.…
Big pharma’s patent cliff meets a new biotech Cold War: We need to outrun China, not outlaw it
If we slash federal research budgets, we risk hamstringing our scientists and losing an otherwise winnable race.…
Radiopharm raises $8.8 million in U.S. and Australian placements
India's pharma sector braces for impact of proposed Trump tariffs on generic drugs
Analysts warn the levies could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies.…
How do you judge the real value of a new Alzheimer’s drug?
Although lecanemab – which costs $30,000 a year – brings modest benefits, we shouldn’t make public drug plan decisions around it in isolation…
Opinion: The U.S. pharmaceutical supply chain problem is not about China
The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes Pooja Yerramilli.…
Chugai Pharmaceutical Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation
2026-07-24. The following slide deck was published by Chugai Pharmaceutical Co., Ltd.…
West Pharmaceutical Earnings: Another Strong Quarter and Upward Guidance Revision - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Zoopharmacognosy — when animals medicate themselves
Explore zoopharmacognosy: how animals self-medicate using plants, revealing fascinating links to human medicinal practices.…
West Pharmaceutical Services, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-07-24. The following slide deck was published by West Pharmaceutical Services, Inc.…
OpenAI formally launches ChatGPT Health feature for all US users - FirstWord Pharma
OpenAI formally launches ChatGPT Health feature for all US users FirstWord Pharma…
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
CEO of Indian pharma company Dr Reddy's has warned that Trump's proposed tariffs on generic drugs will make them more expensive for patients.…
Your recovery may depend on the pharmacist down the street
As a physical therapist, I have seen the same problem countless times. A patient makes steady progress for months, then suddenly plateaus. The exercises have not changed. The injur…
IN BRIEF: Poolbeg Pharma raises GBP3.5 million in share placing - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Sino Biopharm signs AstraZeneca licensing deal, expands GSK tie-up; shares up
There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three new clinical trials could provide possible breakthrough…
America's 250-Year Foundation for Biopharmaceutical Leadership
As America celebrates its 250th birthday, its worth pausing to recognize one of our nations greatest achievements: a legacy of scientific discovery that has transformed and saved…
STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and more
Anthropic announced the availability of Claude Science, which optimizes its large language model for use in scientific labs and by drugmakers…
Zydus, Sunshine Healthcare JV to set up $20 million pharma manufacturing facility in Sri Lanka
Zydus and Sunshine Healthcare are launching a $20 million pharma facility in Sri Lanka to enhance local production and healthcare.…
EMA committee issues negative opinion on MaaT Pharma’s MaaT013
MaaT Pharma Announces Plan to Request Re-Examination Following Negative CHMP Opinion for MaaT013 for the treatment of acute Graft-versus-Host Disease - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Pharma distributor’s licence cancelled over Kota deaths
Rajasthan revoked a pharma distributor's license for supplying fake oxytocin linked to maternal deaths; WHO seeks a report amid ongoing investigations. | India News…
US Starts Section 301 Probe of Germany Over Pharmaceuticals - Bloomberg.com
US Starts Section 301 Probe of Germany Over Pharmaceuticals Bloomberg.com…
Scientists Find Intriguing Link Between Ozempic and Violent Behavior
The same mechanisms that dampen people's cravings for food might also affect our tendency for violent behavior, new research suggests.…
Hate Big Pharma? It Still Might Save Your Life
By every metric, the U.S. pharmaceutical industry dominates the world. The knee-jerk demonization of pharma is lazy and irrational.…
Rhythm Pharmaceuticals reports phase 2 PWS trial results
Sen. Maggie Hassan's report: Spotify removed 3,500 podcast accounts and 57,000 episodes promoting illegal online pharmacies between May and November 2025 (Clare Duffy/CNN)
Clare Duffy / CNN : Sen. Maggie Hassan's report: Spotify removed 3,500 podcast accounts and 57,000 episodes promoting illegal online pharmacies between May and November 2025 — Spot…
First on Fox: Trump admin opens new front in fraud crackdown targeting health insurers, drug middlemen
Trump administration orders insurance companies to investigate fraud in federal employee health programs costing taxpayers about $70 billion annually.…
Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Amylyx Pharmaceuticals, Inc. (AMLX) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 10:40 AM EDTCompany ParticipantsJustin Klee -...…
Ionis Pharmaceuticals, Inc. (IONS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Ionis Pharmaceuticals, Inc. (IONS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 8:40 AM EDTCompany ParticipantsBrett Monia -...…
Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call Prepared Remarks Transcript
Milestone Pharmaceuticals Inc. (MIST) Shareholder/Analyst Call June 10, 2026 11:00 AM EDTCompany ParticipantsJoseph Oliveto - CEO, President & Executive...…
STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and more
A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024…
Lyell Immunopharma, Inc. (LYEL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Lyell Immunopharma, Inc. (LYEL) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 11:20 AM EDTCompany ParticipantsLynn Seely -...…
Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Kiniksa Pharmaceuticals International, plc (KNSA) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 11:20 AM EDTCompany...…
NewAmsterdam Pharma Company N.V. (NAMS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
NewAmsterdam Pharma Company N.V. (NAMS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 2:40 PM EDTCompany ParticipantsMichael...…
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in oncology…